Business Context and Reporting Period
Company: Inotiv, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 2, 2025
Subject: Conclusion of an SEC investigation regarding the importation of non-human primates from Asia and compliance with the U.S. Foreign Corrupt Practices Act.
Financial Metrics
This filing does not contain financial data. Revenue, profit, cash flow, margins, debt, and liquidity metrics are not reported in this document.
Material Changes
The primary material change is the resolution of a regulatory matter. On June 2, 2025, the SEC's Division of Enforcement notified the Company that it has concluded its investigation and does not intend to recommend an enforcement action against Inotiv, Inc. based on information available as of the date of the letter.
Outlook, Risks, and Management Commentary
- Investigation Background: The SEC initially requested documents on May 23, 2023, covering the period from December 1, 2017, to the present. The investigation focused on the Company, Envigo Global Services, Inc., and Orient BioResource Center, Inc., specifically regarding the importation of non-human primates from Asia.
- Procedural History: A formal order of investigation was issued on January 9, 2024, with supplemental document requests provided on April 12, 2024.
- Outcome: The Division of Enforcement has determined not to pursue an enforcement action against the Company.
- Risks: The filing does not disclose new risks or contingencies beyond the concluded investigation.
Key Facts for Investor Verification
- Confirm the finality of the SEC's decision and whether any conditions were attached to the non-enforcement recommendation.
- Verify if the investigation scope included other entities (Envigo Global Services, Inc. and Orient BioResource Center, Inc.) and if those entities received similar outcomes.
- Review prior disclosures to ensure no other pending regulatory matters related to the importation of non-human primates remain unresolved.